Hispanic/Latino (HL) adults bear a greater burden of type 2 diabetes (T2D), and dietary factors have been linked to almost half of cardio-metabolic disease deaths. Avocados are rich in beneficial fats, vitamins, minerals, & fiber. To test the hypothesis that avocado consumption will improve glucose control and cardio-metabolic health in HL adults with or at-risk of T2D, we recruited 59 HL adults (45 women) who were randomized to an Active (A) group - receiving free avocado vouchers for 12 weeks, or a Control (C) group - no avocado vouchers. Subjects (53 T2D, 4 at risk, 2 unknown) had clinical measurements, blood draws, and continuous glucose monitors (CGMs) at Baseline (BL) and Conclusion (CL). Daily avocado consumption logs were kept. At BL, A and C groups did not differ in avocado consumption/day (0.8±0.6 vs 0.5±0.3, respectively). At CL, A group consumption was significantly greater (1.4±0.4 vs 0.4±0.3), p<0.001. Results are shown below. No significant differences between groups were found for time in range (TIR) 70-140 or 70-180 mg/dL or time above (TAR) 180 mg/dL. Providing vouchers to HL adults with or at-risk of T2D significantly increased avocado consumption and did not affect HbA1c, fasting glucose, weight, or CGM metrics but may have influenced waist circumference (WC) and triglycerides.


W. C. Bevier: None. L. Melero: None. S. E. Sato imuro: None. A. Pai: None. M. Gordon: None. K. Gonzalez: None. N. Glantz: None. A. Sabharwal: None. D. Kerr: Consultant; Sanofi-Aventis U. S.


Hass Avocado Board (C2021-0068)

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.